Implantable Defibrillator System Shock Function, Mortality, and Cause of Death After Magnetic Resonance Imaging

被引:0
|
作者
Ra, Joshua [1 ,6 ]
Oberdier, Matt T. T. [2 ]
Suzuki, Masahito [2 ]
Vaidya, Dhananjay [2 ]
Liu, Yisi [3 ]
Hansford, Rozann [2 ]
McVeigh, Diana [2 ]
Weltin, Valeria [2 ]
Tao, Susumu [2 ]
Thiemann, David R. [2 ]
Nazarian, Saman [4 ]
Halperin, Henry R. [5 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Pediat, Baltimore, MD USA
[4] Univ Penn Perelman, Sch Med, Dept Cardiol, Philadelphia, PA USA
[5] Johns Hopkins Univ, Dept Cardiol, Dept Radiol & Biomed Engn, Baltimore, MD USA
[6] Univ Calif San Francisco, Dept Med, 521 Parnassus Ave, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
INDUSTRY VIEWPOINT; SAFE PERFORMANCE; CARDIOVERTER-DEFIBRILLATORS; CLINICAL SAFETY; ABSORPTION RATE; PACEMAKERS; MRI; ICDS; PROTOCOL; DEVICES;
D O I
10.7326/M22-2653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Studies have shown that magnetic resonance imaging (MRI) does not have clinically important effects on the device parameters of non-MRI-conditional implantable cardioverter-defibrillators (ICDs). However, data on non-MRI-conditional ICD detection and treatment of arrhythmias after MRI are limited.Objective: To examine if non-MRI-conditional ICDs have preserved shock function of arrhythmias after MRI.Design: Prospective cohort study. (ClinicalTrials.gov: NCT01130896)Setting: 1 center in the United States.Patients: 629 patients with non-MRI-conditional ICDs enrolled consecutively between February 2003 and January 2015.Interventions: 813 total MRI examinations at a magnetic field strength of 1.5 Tesla using a prespecified safety protocol.Measurements: Implantable cardioverter-defibrillator inter-rogations were collected after MRI. Clinical outcomes included arrhythmia detection and treatment, generator or lead exchanges, adverse events, and death.Results: During a median follow-up of 2.2 years from MRI to latest available ICD interrogation before generator or lead exchange in 536 patients, 4177 arrhythmia episodes were detected, and 97 patients received ICD shocks. Sixty-one patients (10% of total) had 130 spontaneous ventricular tachycardia or fibrillation events terminated by ICD shocks. A total of 210 patients (33% of total) are known to have died (median, 1.7 years from MRI to death); 3 had cardiac arrhythmia deaths where shocks were indicated without direct evidence of device dysfunction.Limitations: Data were acquired at a single center and may not be generalizable to other clinical settings and MRI facilities. Implantable cardioverter-defibrillator interrogations were not avail-able for a subset of patients; adjudication of cause of death relied solely on death certificate data in a subset.Conclusion: Non-MRI-conditional ICDs appropriately treated detected tachyarrhythmias after MRI. No serious adverse effects on device function were reported after MRI.
引用
收藏
页码:289 / 297
页数:10
相关论文
共 50 条
  • [21] A potentially avertable cause of inappropriate shock in a patient with subcutaneous implantable cardioverter defibrillator
    Leventopoulos, Georgios
    Papageorgiou, Angeliki
    Perperis, Angelos
    Koros, Rafail
    Tsigkas, Grigorios
    Davlouros, Periklis
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2022, 45 (07): : 893 - 895
  • [22] Implantable Devices and Magnetic Resonance Imaging
    Hsu, Chijen
    Parker, Geoffrey
    Puranik, Rajesh
    HEART LUNG AND CIRCULATION, 2012, 21 (6-7): : 358 - 363
  • [23] The use of a dual shock lead in an implantable atrial defibrillator system
    Kriplen, M
    Ayers, G
    Reuter, D
    PACEMAKER LEADS 1997, 1997, : 573 - 580
  • [24] THE USE OF CARDIAC MAGNETIC RESONANCE IMAGING TO IDENTIFY CANDIDATES FOR PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    Aznaurov, Sam
    Kusterer, Nathan
    Wilson, Ryan
    Charnigo, Richard
    Leung, Steve
    Elayi, Samy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A385 - A385
  • [25] Food and drug administration perspective - Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients
    Faris, Owen P.
    Shein, Mitchell
    CIRCULATION, 2006, 114 (12) : 1232 - 1233
  • [26] Sudden death during surgery for an implantable cardioverter/defibrillator system
    Albalooshi, Y.
    Doberentz, E.
    Madea, B.
    RECHTSMEDIZIN, 2010, 20 (05) : 415 - 418
  • [27] Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe - In vitro and in vivo assessment of safety and function at 1.5 T
    Roguin, A
    Zviman, MM
    Meininger, GR
    Rodrigues, ER
    Dickfeld, TM
    Bluemke, DA
    Lardo, A
    Berger, RD
    Calkins, H
    Halperin, HR
    CIRCULATION, 2004, 110 (05) : 475 - 482
  • [28] Evaluation and management of patients after implantable cardioverter-defibrillator shock
    Gehi, Anil K.
    Mehta, Davendra
    Gomes, J. Anthony
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (23): : 2839 - 2847
  • [29] Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come?
    Nordbeck, Peter
    Ertl, Georg
    Ritter, Oliver
    EUROPEAN HEART JOURNAL, 2015, 36 (24) : 1505 - U81
  • [30] Cardiac magnetic resonance imaging and primary prevention implantable cardioverter defibrillator therapy: current recommendations and future directions
    Guaricci, Andrea I.
    De Santis, Delia
    Rabbat, Mark G.
    Pontone, Gianluca
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (05) : 223 - 228